Physician profile
Andrew D Lundquist
NPI 1235290420
$8,683.96
in general payments reported to CMS, 2019-2025
9 companies · $5,954 in 2025
The $5,954 reported for 2025 was more than what 94% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.53 · 2020: $12.21 · 2021: $1,200 · 2022: $1,220 · 2023: $269 · 2025: $5,954.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,500 · Travel and Lodging: $1,499 · Food and Beverage: $1,224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,500.00 |
| Travel and Lodging | $1,498.83 |
| Food and Beverage | $1,224.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trimed, INC. | $5,944.33 | 2025 | |
| Gemini Medical LLC | $2,400.00 | 2021-2022 | |
| Stryker Corporation | $142.78 | 2023 | Infinity, Axsos, Augment Injectable |
| Exactech, INC. | $126.36 | 2023 | |
| Smith+Nephew, INC. | $20.35 | 2022 | |
| Amgen INC. | $14.52 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $14.01 | 2019 | |
| Organogenesis INC. | $12.21 | 2020 | |
| Kerecis Limited | $9.40 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Lundquist listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.